Skip to main content

miRNA and mRNA Expression Analysis of Human Breast Cancer Subtypes to Identify New Markers

  • Conference paper
  • First Online:
Book cover Computational Intelligence in Communications and Business Analytics (CICBA 2022)

Abstract

MicroRNAs (miRNAs) play a key role in the regulation of gene expression. Perfect or in-perfect complementarity of binding between miRNAs and a messenger RNA (mRNA) may lead to mRNA degradation or translational inhibition. In this regard, we have explored the role of miRNA and their target mRNAs in tumorous and normal tissues of molecular breast cancer subtypes such as Basal, human epidermal growth factor receptor 2, luminal A, and luminal B. Thus, we have carried out this research using the expression profile of 825 patient samples. For this analysis, a comparative analysis between the tumorous and adjacent normal groups of samples is conducted. The major finding of this research is the identification of the most significant miRNAs and their corresponding significant target mRNAs associated with the breast cancer subtypes. The biological significance of the identified miRNAs and their target mRNAs are validated by KEGG pathway analysis, gene ontology enrichment analysis, and survival analysis. Moreover, we report a comparison of our method with the panel selection strategies of DESeq and edgeR based on differentially expressed miRNAs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    http://www.enrichnet.org/.

References

  1. Adhami, M., Haghdoost, A.A., Sadeghi, B., Malekpour Afshar, R.: Candidate miRNAs in human breast cancer biomarkers: a systematic review. Breast Cancer 25(2), 198–205 (2017). https://doi.org/10.1007/s12282-017-0814-8

    Article  Google Scholar 

  2. Alexiou, P., Maragkakis, M., Papadopoulos, G.L., Simmosis, V.A., Zhang, L., Hatzigeorgiou, A.G.: The DIANA-mirExTra web server: from gene expression data to microRNA function. PloS one 5(2), e9171 (2010)

    Article  Google Scholar 

  3. Anders, S., Huber, W.: Differential expression analysis for sequence count data. Genome Biol. 11(10), R106 (2010)

    Article  Google Scholar 

  4. Benjamini, Y., Hochberg, Y.: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Society Ser. B (Methodological) 57, 289–300 (1995)

    MathSciNet  MATH  Google Scholar 

  5. Bhowmick, S.S., Bhattacharjee, D., Rato, L.: In silico markers: an evolutionary and statistical approach to select informative genes of human breast cancer subtypes. Genes Genom. 41(12), 1371–1382 (2019)

    Article  Google Scholar 

  6. Bhowmick, S.S., Bhattacharjee, D., Rato, L.: Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types. Comput. Biol. Chem. 84, 107152 (2020)

    Article  Google Scholar 

  7. Blenkiron, C., et al.: MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8(10), 1–16 (2007)

    Article  Google Scholar 

  8. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A.: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394–424 (2018)

    Article  Google Scholar 

  9. Calin, G.A., Croce, C.M.: MicroRNA signatures in human cancers. Nat. Rev. Cancer 6(11), 857–866 (2006)

    Article  Google Scholar 

  10. Dalman, M.R., Deeter, A., Nimishakavi, G., Duan, Z.H.: Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinf. 13(2), 1 (2012)

    Google Scholar 

  11. Foekens, J.A., et al.: Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. 105(35), 13021–13026 (2008)

    Article  Google Scholar 

  12. Grada, A., Weinbrecht, K.: Next-generation sequencing: methodology and application. J. Invest. Dermatol. 133(8), e11 (2013)

    Article  Google Scholar 

  13. He, L., Hannon, G.J.: MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5(7), 522–531 (2004)

    Article  Google Scholar 

  14. Iorio, M.V., et al.: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65(16), 7065–7070 (2005)

    Article  Google Scholar 

  15. Kuleshov, M.V., et al.: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res., gkw377 (2016)

    Google Scholar 

  16. Liang, Z., Zhou, H., He, Z., Zheng, H., Wu, J.: mirAct: a web tool for evaluating microRNA activity based on gene expression data. Nucleic Acids Res. 39(suppl_2), W139–W144 (2011)

    Google Scholar 

  17. Lu, J., et al.: MicroRNA expression profiles classify human cancers. Nature 435(7043), 834–838 (2005)

    Article  Google Scholar 

  18. Lu, T.P., Lee, C.Y., Tsai, M.H., Chiu, Y.C., Hsiao, C.K., Lai, L.C., Chuang, E.Y.: miRSystem: an integrated system for characterizing enriched functions and pathways of microRNA targets. PloS one 7(8), e42390 (2012)

    Article  Google Scholar 

  19. Mattie, M.D.: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Molec. Cancer 5(1), 1–14 (2006)

    Article  Google Scholar 

  20. Oh, M., et al.: Literature-based condition-specific miRNA-mRNA target prediction. PloS one 12(3), e0174999 (2017)

    Article  Google Scholar 

  21. Pepe, M.S., Mori, M.: Kaplan-meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat. Med. 12(8), 737–751 (1993)

    Article  Google Scholar 

  22. Rasmussen, S.H., Jacobsen, A., Krogh, A.: cWords-systematic microRNA regulatory motif discovery from mRNA expression data. Silence 4(1), 2 (2013)

    Article  Google Scholar 

  23. de Rinaldis, E., et al.: Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control. BMC Genom. 14(1), 643 (2013)

    Article  Google Scholar 

  24. Robinson, M.D., McCarthy, D.J., Smyth, G.K.: edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1), 139–140 (2010)

    Article  Google Scholar 

  25. Sørlie, T., et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. 98(19), 10869–10874 (2001)

    Article  Google Scholar 

  26. Steinfeld, I., Navon, R., Ach, R., Yakhini, Z.: miRNA target enrichment analysis reveals directly active miRNAs in health and disease. Nucleic Acids Res. 41(3), e45–e45 (2012)

    Article  Google Scholar 

  27. Vikram, R., Ramachandran, R., Abdul, K.S.M.: Functional significance of long non-coding RNAs in breast cancer. Breast Cancer 21(5), 515–521 (2014). https://doi.org/10.1007/s12282-014-0554-y

    Article  Google Scholar 

  28. Volinia, S., Croce, C.M.: Prognostic microrna/mrna signature from the integrated analysis of patients with invasive breast cancer. Proc. Natl. Acad. Sci. 110(18), 7413–7417 (2013)

    Article  Google Scholar 

  29. Weinstein, J.N., et al.: The cancer genome atlas pan-cancer analysis project. Nat. Genet. 45(10), 1113–1120 (2013)

    Article  Google Scholar 

  30. Zhuang, X., et al.: Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in non-obstructive azoospermia. Sci. Rep. 5, 1–9 (2015)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shib Sankar Bhowmick .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Bhowmick, S.S., Bhattacharjee, D. (2022). miRNA and mRNA Expression Analysis of Human Breast Cancer Subtypes to Identify New Markers. In: Mukhopadhyay, S., Sarkar, S., Dutta, P., Mandal, J.K., Roy, S. (eds) Computational Intelligence in Communications and Business Analytics. CICBA 2022. Communications in Computer and Information Science, vol 1579. Springer, Cham. https://doi.org/10.1007/978-3-031-10766-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-10766-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-10765-8

  • Online ISBN: 978-3-031-10766-5

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics